FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

BRS Analytical Services Polyvinyl Alcohol Ophthalmic Solution 1 Recall

Polyvinyl Alcohol Ophthalmic Solution 1

BRS Analytical Services, LLC · Saint Louis, MO

Risk level
Class II
Reported by FDA
May 14, 2025
Recall ID
D-0408-2025
Check your lot numberHow we source this data

Summary

BRS Analytical Services recalled Polyvinyl Alcohol Ophthalmic Solution 1 starting Apr 23, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0408-2025 on May 14, 2025. Reason: cGMP deviations and lack of assurance of sterility. Status: Ongoing.

Why it was recalled

cGMP deviations and lack of assurance of sterility.

Product description

Polyvinyl Alcohol Ophthalmic Solution 1.4%, Lubricant Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-678-15.

Lot numbers, UPCs & expiration codes

Lot, expiry: Lot 120, exp 10/02/25; Lot 122, exp 10/09/25; Lot 123, exp 10/12/25; Lot 124, exp 10/16/25; Lot 138, exp 1/08/26; Lot 142, exp 1/29/26; Lot 143, exp 2/01/26; Lot 144, exp 2/07/26; Lot 145, exp 2/12/26; Lot 146, exp 2/15/26; Lot 147, exp 2/21/26; Lot 148, exp 2/27/26; Lot 149, exp 3/04/26; Lot 150, exp 3/11/26; Lot 158, exp 4/15/26; Lot 159, exp 4/22/26; Lot 176, exp 7/24/26; Lot 177, exp 7/28/26; Lot 178, exp 7/31/26; Lot 179, exp 8/05/26.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0408-2025
Classification
Class II
Status
Ongoing
Recall initiated
Apr 23, 2025
FDA report date
May 14, 2025
Quantity
14,333 cases (24 cartons per case)
Recall type
Voluntary: Firm initiated
Recalling firm
BRS Analytical Services, LLC

Original FDA data

Every field from FDA enforcement report D-0408-2025, exactly as published.

Show all FDA fields
City
Saint Louis
State
MO
Status
Ongoing
Country
United States
Event ID
96741
Address
11697 Lakeside Crossing Ct
Code information
Lot, expiry: Lot 120, exp 10/02/25; Lot 122, exp 10/09/25; Lot 123, exp 10/12/25; Lot 124, exp 10/16/25; Lot 138, exp 1/08/26; Lot 142, exp 1/29/26; Lot 143, exp 2/01/26; Lot 144, exp 2/07/26; Lot 145, exp 2/12/26; Lot 146, exp 2/15/26; Lot 147, exp 2/21/26; Lot 148, exp 2/27/26; Lot 149, exp 3/04/26; Lot 150, exp 3/11/26; Lot 158, exp 4/15/26; Lot 159, exp 4/22/26; Lot 176, exp 7/24/26; Lot 177, exp 7/28/26; Lot 178, exp 7/31/26; Lot 179, exp 8/05/26.
Postal code
63146-8606
Report date
May 14, 2025
Product type
Drugs
Recall number
D-0408-2025
Classification
Class II
Recalling firm
BRS Analytical Services, LLC
Product quantity
14,333 cases (24 cartons per case)
Reason for recall
cGMP deviations and lack of assurance of sterility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Polyvinyl Alcohol Ophthalmic Solution 1.4%, Lubricant Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-678-15.
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 23, 2025
Initial firm notification
Letter
Center classification date
May 6, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0408-2025, published May 14, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls